Zhang Changmao, Xie Chengrong, Wang Xiaomin, Huang Yayu, Gao Shaoyang, Lu Jing, Lu Yuyan, Zhang Sheng
Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital of Xiamen University Xiamen 361004, China.
Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University Quanzhou 362000, China.
Am J Cancer Res. 2020 May 1;10(5):1416-1428. eCollection 2020.
Growing evidence indicates that deubiquitinase ubiquitin-specific protease 11 (USP11) plays an important role in cellular function by regulating the stability of its substrates. USP11 is dysregulated in many types of cancer and involved in tumor development and progression. We previously showed that USP11 was upregulated in hepatocellular carcinoma (HCC) and promoted HCC cell invasion and metastasis potency. However, the mechanism underlying the role of USP11 in HCC cell metastasis and its function in cell proliferation remain unknown. Here, CCK-8, soft agar assays and nude mouse models showed that USP11 was essential for HCC cells survival and proliferation and . Results form mass spectrometry, co-immunoprecipitation, and ubiquitination assays demonstrated that USP11 interacted with nuclear factor 90 (NF90) and promoted its deubiquitination, thereby stabilizing it in HCC cells. Moreover, the effect of USP11 on promoting HCC cells proliferation and metastasis was dependent on NF90, and USP11 expression was positively correlated with NF90 expression in human HCC tissues, as demonstrated via immunohistochemistry. Collectively, the present findings indicated that USP11 binded to and deubiquitinated NF90, thereby stabilizing the protein expression level and promoting HCC cell proliferation and metastasis. NF90 was identified as an important downstream target of USP11. Dysregulated signaling of this novel USP11/NF90 axis might promote HCC proliferation and metastasis, and the axis could be a potential therapeutic target in HCC.
越来越多的证据表明,去泛素化酶泛素特异性蛋白酶11(USP11)通过调节其底物的稳定性在细胞功能中发挥重要作用。USP11在多种癌症中表达失调,并参与肿瘤的发生和发展。我们之前发现USP11在肝细胞癌(HCC)中上调,并促进HCC细胞的侵袭和转移能力。然而,USP11在HCC细胞转移中发挥作用的机制及其在细胞增殖中的功能仍不清楚。在此,CCK-8、软琼脂试验和裸鼠模型表明,USP11对HCC细胞的存活和增殖至关重要。质谱、免疫共沉淀和泛素化试验结果表明,USP11与核因子90(NF90)相互作用并促进其去泛素化,从而在HCC细胞中使其稳定。此外,USP11对促进HCC细胞增殖和转移的作用依赖于NF90,免疫组织化学结果表明,在人HCC组织中USP11表达与NF90表达呈正相关。总的来说,目前的研究结果表明,USP11与NF90结合并使其去泛素化,从而稳定蛋白表达水平并促进HCC细胞增殖和转移。NF90被确定为USP11的一个重要下游靶点。这个新的USP11/NF90轴的信号失调可能促进HCC的增殖和转移,并且该轴可能是HCC的一个潜在治疗靶点。